Trial Profile
Oxaliplatin Phase II Trial in Association With 5FU and Folinic Acid in the Treatment of Advanced Unresectable or Metastatic Gastric Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 08 Nov 2010 Actual end date (Jul 2006) added as reported by ClinicalTrials.gov.
- 24 Aug 2006 New trial record.